PatternsRadar
Sign in

GRANULESGranules India Limited

NSE
Full chart
836.40INR+19.15 (+2.34%)Close · 6 Oct 2026
21 Jul 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹20,726 CrMarket cap
31.3P/E (TTM)
56.4%Delivery

Filings & corporate actions

77 results filed
CSV
Next results · Q2 FY27
Expected 20 Oct 2026 – 13 Nov 2026
Estimate: filed 20–44 days after quarter end, last 5 times
Dividend
₹1.75 per share · last 30 Jul 2026
2026
  • 30 JuldividendDividend · ₹1.75 per share-0.9%
  • 21 JulresultsResults · Q1 FY27 · consolidated and standalone0.0%NSE
  • 3 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
  • 29 AprresultsResults · Q4 FY26 · consolidated and standalone-0.7%NSE
  • 6 AprshareholdingShareholding · 31 Mar 2026+5.0%NSE
  • 26 FebshareholdingShareholding · 23 Feb 2026-1.5%NSE
  • 23 JanresultsResults · Q3 FY26 · consolidated and standalone+2.5%NSE
  • 14 JanshareholdingShareholding · 31 Dec 2025+1.4%NSE

Reaction to results · all yearsrose on day 0 in 27 of 76 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2721 Jul 20260.0%-3.5%-2.8%2.5×
Q4 FY2629 Apr 2026-0.7%+6.9%+10.6%1.2×
Q3 FY2623 Jan 2026+2.5%-2.2%+6.1%2.3×
Q2 FY2613 Nov 2025-1.5%-2.2%+3.3%1.6×
Q1 FY2612 Aug 2025+3.3%+4.7%+19.4%2.0×
Q4 FY2528 May 2025-1.2%-0.3%-6.6%1.9×
Q3 FY2524 Jan 2025-2.9%-7.2%-12.1%2.1×
Q2 FY256 Nov 2024-0.8%-7.4%+0.6%2.8×
Q1 FY2530 Jul 2024+4.3%+14.9%+25.1%3.1×
Q4 FY2415 May 2024+0.8%+8.2%+16.5%1.5×
Q3 FY2423 Jan 2024-1.1%-0.2%+9.8%2.2×
Q2 FY249 Nov 2023-1.0%+0.7%+4.1%1.0×
Q1 FY249 Aug 2023-6.4%-9.9%-3.0%3.8×
Q4 FY2316 May 2023-0.8%-3.2%-0.4%4.4×
Q3 FY2326 Jan 2023-1.8%+1.1%-1.2%1.6×
Q2 FY2320 Oct 2022-1.0%+7.1%+4.2%0.5×
Q1 FY239 Aug 2022-3.9%+3.6%-1.4%3.1×
Q4 FY2218 May 2022-6.7%-1.7%-9.0%2.2×
Q3 FY228 Feb 2022-0.7%-0.7%-5.3%1.0×
Q2 FY2212 Nov 2021-2.7%+0.8%+9.5%8.0×
Q1 FY2227 Jul 2021+1.9%+6.1%-10.5%2.3×
Q4 FY2111 May 2021-1.1%-9.7%-8.4%3.8×
Q3 FY2128 Jan 2021-4.6%-4.7%-8.5%1.3×
Q2 FY2120 Oct 2020+0.1%-1.8%-0.1%1.8×
Q1 FY2117 Jul 2020+7.4%+23.4%+24.9%5.7×
Q4 FY202 Jun 2020+0.2%+12.5%+17.1%2.5×
Q3 FY2021 Jan 2020+6.6%+9.5%+34.3%2.3×
Q2 FY2022 Oct 2019+1.2%+9.6%+14.5%2.6×
Q1 FY2030 Jul 2019-1.2%+1.0%-0.2%15.4×
Q4 FY199 May 2019-3.0%-6.8%-5.7%2.6×
Q3 FY191 Feb 2019-2.4%-5.1%+13.8%0.7×
Q2 FY199 Nov 2018+1.3%-3.0%-21.5%0.4×
Q1 FY197 Aug 2018-3.8%-1.0%+12.9%0.4×
Q4 FY1828 May 2018+0.4%-6.5%+3.9%1.8×
Q3 FY1814 Feb 2018-3.4%-7.9%-9.4%0.9×
Q2 FY1711 Nov 2017-2.9%-0.9%+4.1%0.7×
Q2 FY1811 Nov 2017-2.9%-0.9%+4.1%0.7×
Q1 FY1824 Aug 2017+0.4%-2.3%-8.0%0.4×
Q4 FY1724 May 2017-4.2%-1.2%-1.2%1.4×
Q3 FY1730 Jan 2017+1.0%+11.3%+17.1%0.9×
Q1 FY1728 Sept 2016+0.2%-0.4%-0.8%1.0×
Q4 FY1629 Apr 2016-2.2%-3.2%+1.2%1.0×
Q3 FY161 Feb 2016+0.5%+5.6%-1.1%0.7×
Q2 FY162 Nov 2015+0.3%+0.4%+8.7%1.0×
Q1 FY1623 Jul 2015+5.7%+11.3%+26.1%1.7×
Q4 FY1528 Apr 2015-6.7%+2.2%-2.4%1.3×
Q3 FY1531 Jan 2015+1.2%-2.8%-5.1%0.4×
Q2 FY154 Nov 2014-2.3%0.0%-4.5%0.9×
Q1 FY155 Aug 2014+0.8%-1.6%+18.8%0.5×
Q4 FY142 May 2014+1.3%+5.0%+5.2%0.7×
Q3 FY1431 Jan 2014+0.7%+22.7%+19.6%0.5×
Q2 FY1428 Nov 2013-0.3%+9.7%+17.6%0.5×
Q1 FY1430 Jul 2013-1.5%-9.5%-7.7%0.3×
Q4 FY134 May 2013-1.5%+9.2%+1.5%0.2×
Q3 FY1325 Jan 2013-6.4%-12.1%-18.9%3.5×
Q2 FY1325 Oct 2012-1.3%-6.0%-14.2%1.0×
Q1 FY1326 Jul 2012-3.0%+14.1%+17.5%0.8×
Q4 FY1224 Apr 2012-1.0%-3.9%-9.3%3.7×
Q3 FY1224 Jan 2012+12.1%+7.6%+19.7%61.9×
Q2 FY1217 Oct 2011-2.1%-9.2%-10.6%1.3×
Q1 FY1228 Jul 2011-1.1%-14.4%-20.7%0.7×
Q3 FY1127 Jan 20110.0%-4.8%-1.6%5.1×
Q2 FY1128 Oct 2010-0.5%-2.0%-8.0%0.2×
Q1 FY1126 Jul 2010-3.5%-9.0%-5.0%5.1×
Q3 FY1022 Jan 2010-2.0%-7.7%-8.7%2.1×
Q2 FY1026 Oct 2009+0.5%-12.6%0.0%1.4×
Q1 FY1025 Jul 2009+10.9%+11.7%+21.1%11.2×
Q4 FY0925 Apr 20090.0%-1.1%+22.2%0.6×
Q3 FY0929 Jan 20090.0%+2.8%0.0%0.5×
Q2 FY0920 Oct 2008+4.1%-9.5%-6.8%0.8×
Q1 FY095 Aug 2008-0.9%-1.8%+1.8%0.5×
Q4 FY0830 Apr 2008-1.2%-5.5%-17.1%0.8×
Q3 FY0824 Jan 2008+5.8%+6.4%+12.2%0.2×
Q2 FY0827 Oct 2007-1.0%+4.1%-1.5%0.9×
Q1 FY0830 Jul 2007-1.3%-9.0%-14.5%0.3×
Q4 FY0730 Apr 2007-0.4%+5.4%+7.5%0.7×
Average-0.4%+0.3%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+22.0%
Profit YoY+59.8%
Interest cost YoY—
Revenue QoQ+0.4%
Profit QoQ-10.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open818.00
Day range814.75 – 839.00
52-week range510.90 – 923.65
From 52w high-9.4%
RSI (14)45.6
ATR (14)27.88
Volume5.18L
Avg volume (20D)13.86L
Rel volume0.37×
Volatility (1Y)29.4%
Turnover₹43.3Cr
SMA 50 / 200852.70 / 719.95

Delivery percentage

Latest · 6 Oct 202656.4%
20-day avg50.9%
1-year avg50.4%
Percentile (own history)92nd
Range8.2–93.6%
Sessions1,731

Over the last 20 sessions GRANULES settled 50.9% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 50.4%. The latest session ranks higher than 92% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+2.34%-1.76%-2.04%-3.14%+36.31%+62.12%

Valuation

CSV
Market cap₹20,726 Cr
P/E (TTM)31.3
EPS (TTM)26.73
Shares outstanding24.78Cr
Listed20 Jun 2005

Ownership

CSV
Promoter38.02%
Promoter Δ QoQ0.00 pp
Public61.98%
FII17.50%
DII16.11%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)1,297.01,387.91,470.61,476.8
YoY chg——+22.8%+22.0%
Net profit (₹ Cr)130.6150.2201.6180.0
YoY chg——+32.6%+59.8%
Net margin10.1%10.8%13.7%12.2%
EPS5.386.198.237.12

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 38.02% · public 61.98%
30 Sept 2021: promoter 42.04%31 Dec 2021: promoter 41.98%31 Mar 2022: promoter 41.98%30 Jun 2022: promoter 41.98%30 Sept 2022: promoter 41.93%19 Oct 2022: promoter 42.02%31 Dec 2022: promoter 42.02%31 Mar 2023: promoter 42.02%30 Jun 2023: promoter 42.02%30 Sept 2023: promoter 41.96%31 Dec 2023: promoter 41.96%31 Mar 2024: promoter 41.96%30 Jun 2024: promoter 38.87%30 Sept 2024: promoter 38.87%31 Dec 2024: promoter 38.85%31 Mar 2025: promoter 38.84%30 Jun 2025: promoter 38.82%30 Sept 2025: promoter 38.82%31 Dec 2025: promoter 38.82%23 Feb 2026: promoter 38.02%31 Mar 2026: promoter 38.02%30 Jun 2026: promoter 38.02%
2021-092026-06
  • Promoter
  • Public and others
Promoter
38.02%
Public
61.98%
Promoter change
0.00 pp
Filed
3 Jul 2026
FII
17.50%
DII
16.11%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations1,189.51,155.61,175.81,179.9966.61,137.71,197.41,210.11,297.01,387.91,470.61,476.8
Other income1.50.71.92.13.35.71.916.3(1.1)(3.6)8.82.3
Total income1,191.01,156.21,177.71,181.9969.91,143.41,199.41,226.51,295.81,384.31,479.41,479.0
Total expenses1,055.0986.11,002.01,000.5841.5990.61,032.61,056.01,120.01,182.11,232.91,238.6
└ Finance costs26.028.628.827.025.726.624.023.829.228.732.721.1
└ Depreciation52.552.453.252.952.556.663.568.872.073.581.779.6
Profit before tax136.0170.1175.6181.4128.4152.8197.6144.5175.9202.2262.4240.4
Tax expense33.944.446.046.831.135.245.531.945.352.060.860.4
Net profit102.1125.7129.6134.697.2117.6152.0112.6130.6150.2201.6180.0
EPS4.225.185.355.564.014.856.274.645.386.198.237.26
Net margin8.58%10.87%11.03%11.41%10.06%10.34%12.70%9.31%10.07%10.82%13.71%12.19%
PBT margin11.44%14.72%14.94%15.38%13.28%13.43%16.50%11.94%13.56%14.57%17.84%16.28%
Tax rate24.93%26.13%26.19%25.79%24.26%23.03%23.04%22.06%25.74%25.72%23.17%25.14%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 21 Jul 2026.

GRANULES at a glance

  • GRANULES closed at ₹836.4 on 6 Oct 2026, +2.34% on the day, +62.1% over one year, 9.4% below its 52-week high of ₹923.65.
  • Delivery was 56.4% of traded quantity on 6 Oct 2026, the 92nd percentile of its own 1,731 sessions with a reading (20-session average 50.9%, 1-year average 50.4%).
  • Market capitalisation is ₹20,726 crore at a trailing P/E of 31.3 (trailing EPS ₹26.73).
  • Q1 FY27 results (consolidated, filed 21 Jul 2026): revenue ₹1,477 crore (+22.0% year on year), net profit ₹180 crore (+59.8%); the price moved 0.0% on the first session after.
  • Promoters held 38.02% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 20 Oct 2026 and 13 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE101D01020
SeriesEQ
Listed20 Jun 2005
History from20 Jun 2005
Sessions5,275
Turnover rank#263

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE